Form 4 for LRCX Lam Research
Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-17 · accession 0001343600-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-18 | 2025-12-17 | LRCX | ARCHER TIMOTHY | Pres, CEO | S - Sale+OE | $163.86 | -163.3K | 932.4K | -15% | -$26.76M |
| D | 2025-12-18 | 2025-12-17 | LRCX | ARCHER TIMOTHY | Pres, CEO | M - OptEx | $17.68 | +113.3K | 1.05M | +12% | +$2.00M |
| D | 2025-12-18 | 2025-12-17 | LRCX | ARCHER TIMOTHY | Pres, CEO | M - OptEx | $0.00 | -113.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-17 | S | D | 113,300 | $163.86 | 932,409 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025 (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2025-12-17 | S | D | 50,000 | $163.86 | 932,409 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025 (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Common | Common Stock | 2025-12-17 | M | A | 113,300 | $17.68 | 1,045,709 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025 (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2025-12-17 | M | D | 113,300 | $0.00 | 0 | D | $17.68 · — to 2026-03-01 | 113,300 Common Stock | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025 (F3) The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022. |